Listing 1 - 6 of 6 |
Sort by
|
Choose an application
Health statistics have progressed dramatically in Australia since the 1980s when the Australian Government created the (now) Australian Institute of Health and Welfare. The 12 papers in this Special Issue describe developments across a diverse range of topics, as well as providing an overview of the scope of health statistics in Australia and describing some ongoing gaps and problems. The papers will be of interest to international readers seeking to improve statistics about their health systems. Health statistics need to respect individuals’ personal information, be based on common data standards, and have adequate resourcing and committed staffing . The Australian experience provides valuable insights and examples. Australians will benefit from a comprehensive account of what has been achieved and what remains to be addressed. The papers in the Special Issue demonstrate the importance of continuing commitment to the statistical effort. Authors were chosen because of their known expertise in their respective fields.
Humanities --- Social interaction --- Aboriginal and Torres Strait Islander health --- Indigenous health measurement --- life expectancy --- misleading statistics --- management use of information --- data sovereignty --- governance --- mental --- services --- pandemic --- COVID-19 --- data linkage --- Australia --- cross-jurisdiction --- dental caries --- oral health --- periodontal disease --- tooth loss --- health services --- disability --- data gaps --- disability identification --- International Classification of Functioning, Disability and Health (ICF) --- Convention on the Rights of Persons with Disabilities (CRPD) --- health statistics, disability statistics --- inequalities --- prescribing --- quality use of medicines --- medication safety --- pharmacoepidemiology --- medication data --- health outcomes --- real-world data --- real-world evidence --- mortality data --- cause of death --- coronial investigation --- continuity of care --- data --- dementia --- health --- health service use --- integration --- last year of life --- linkage --- suicide --- veterans --- welfare --- wellbeing --- general practice --- health services research --- primary health care --- health expenditure --- health expenditure projections --- disease expenditure --- health expenditure policy --- mental health --- accountability --- quality improvement --- policy development --- health statistics --- Australian health system --- health surveys --- Indigenous
Choose an application
Health statistics have progressed dramatically in Australia since the 1980s when the Australian Government created the (now) Australian Institute of Health and Welfare. The 12 papers in this Special Issue describe developments across a diverse range of topics, as well as providing an overview of the scope of health statistics in Australia and describing some ongoing gaps and problems. The papers will be of interest to international readers seeking to improve statistics about their health systems. Health statistics need to respect individuals’ personal information, be based on common data standards, and have adequate resourcing and committed staffing . The Australian experience provides valuable insights and examples. Australians will benefit from a comprehensive account of what has been achieved and what remains to be addressed. The papers in the Special Issue demonstrate the importance of continuing commitment to the statistical effort. Authors were chosen because of their known expertise in their respective fields.
Aboriginal and Torres Strait Islander health --- Indigenous health measurement --- life expectancy --- misleading statistics --- management use of information --- data sovereignty --- governance --- mental --- services --- pandemic --- COVID-19 --- data linkage --- Australia --- cross-jurisdiction --- dental caries --- oral health --- periodontal disease --- tooth loss --- health services --- disability --- data gaps --- disability identification --- International Classification of Functioning, Disability and Health (ICF) --- Convention on the Rights of Persons with Disabilities (CRPD) --- health statistics, disability statistics --- inequalities --- prescribing --- quality use of medicines --- medication safety --- pharmacoepidemiology --- medication data --- health outcomes --- real-world data --- real-world evidence --- mortality data --- cause of death --- coronial investigation --- continuity of care --- data --- dementia --- health --- health service use --- integration --- last year of life --- linkage --- suicide --- veterans --- welfare --- wellbeing --- general practice --- health services research --- primary health care --- health expenditure --- health expenditure projections --- disease expenditure --- health expenditure policy --- mental health --- accountability --- quality improvement --- policy development --- health statistics --- Australian health system --- health surveys --- Indigenous
Choose an application
Health statistics have progressed dramatically in Australia since the 1980s when the Australian Government created the (now) Australian Institute of Health and Welfare. The 12 papers in this Special Issue describe developments across a diverse range of topics, as well as providing an overview of the scope of health statistics in Australia and describing some ongoing gaps and problems. The papers will be of interest to international readers seeking to improve statistics about their health systems. Health statistics need to respect individuals’ personal information, be based on common data standards, and have adequate resourcing and committed staffing . The Australian experience provides valuable insights and examples. Australians will benefit from a comprehensive account of what has been achieved and what remains to be addressed. The papers in the Special Issue demonstrate the importance of continuing commitment to the statistical effort. Authors were chosen because of their known expertise in their respective fields.
Humanities --- Social interaction --- Aboriginal and Torres Strait Islander health --- Indigenous health measurement --- life expectancy --- misleading statistics --- management use of information --- data sovereignty --- governance --- mental --- services --- pandemic --- COVID-19 --- data linkage --- Australia --- cross-jurisdiction --- dental caries --- oral health --- periodontal disease --- tooth loss --- health services --- disability --- data gaps --- disability identification --- International Classification of Functioning, Disability and Health (ICF) --- Convention on the Rights of Persons with Disabilities (CRPD) --- health statistics, disability statistics --- inequalities --- prescribing --- quality use of medicines --- medication safety --- pharmacoepidemiology --- medication data --- health outcomes --- real-world data --- real-world evidence --- mortality data --- cause of death --- coronial investigation --- continuity of care --- data --- dementia --- health --- health service use --- integration --- last year of life --- linkage --- suicide --- veterans --- welfare --- wellbeing --- general practice --- health services research --- primary health care --- health expenditure --- health expenditure projections --- disease expenditure --- health expenditure policy --- mental health --- accountability --- quality improvement --- policy development --- health statistics --- Australian health system --- health surveys --- Indigenous
Choose an application
In this reprint, we hope to review the basics and highlight the latest developments in AMD. This demonstrates the benefits of the international scientific community working on this disease, to limit its negative impacts, the most vital of which is the loss of visual function, leading to a loss of autonomy and a decrease in patients’ quality of life.
Medicine --- aflibercept monotherapy --- polypoidal choroidal vasculopathy --- neovascular age-related macular degeneration --- good baseline visual acuity --- ForeseeHome AMD Monitoring System® --- AREDS2-HOME study --- age-related macular degeneration --- exudation --- optical coherence tomography angiography --- anti-vascular endothelial growth factor --- brolucizumab --- epithelial tear --- optical coherence tomography --- Sorsby’s fundus dystrophy --- Sorsby --- hereditary retinal dystrophy --- choroidal neovascularisation --- macular neovascularization --- anti-VEGF treatment --- long-term FU --- treatment outcome --- emerging treatment --- neovascular age-related macular degeneration (nAMD) --- Vascular Endothelial Growth Factor (VEGF) --- cataract surgery --- clinical trials --- real-world evidence --- AMD --- oct-angiography --- fellow eye --- choriocapillaris --- quiescent macular neovascularization --- ranibizumab --- aflibercept --- anti-VEGF --- visual acuity --- reading acuity --- disease activity --- treatment change --- treat and extend --- switch therapy --- retina --- choroidal neovascularization --- angiogenesis --- meteorin --- therapeutic innovation --- prevention --- nutrients --- lifestyle --- treatment-naive --- anti–vascular endothelial growth factor --- cardiovascular risk factors --- arterial hypertension --- macula-off rhegmatogenous detachment --- superficial perifoveal capillary plexus --- retinal deep perifoveal capillary plexus --- identification --- risk --- Delphi --- STARS® --- food supplement --- bevacizumab --- meta-analysis --- meta-regression --- n/a --- age-related macular degeneration (AMD) --- comparative therapies --- effectiveness --- intravitreal anti-vascular endothelial growth factor --- treat-and-extend --- pro re nata regimen --- Sorsby's fundus dystrophy
Choose an application
In this reprint, we hope to review the basics and highlight the latest developments in AMD. This demonstrates the benefits of the international scientific community working on this disease, to limit its negative impacts, the most vital of which is the loss of visual function, leading to a loss of autonomy and a decrease in patients’ quality of life.
aflibercept monotherapy --- polypoidal choroidal vasculopathy --- neovascular age-related macular degeneration --- good baseline visual acuity --- ForeseeHome AMD Monitoring System® --- AREDS2-HOME study --- age-related macular degeneration --- exudation --- optical coherence tomography angiography --- anti-vascular endothelial growth factor --- brolucizumab --- epithelial tear --- optical coherence tomography --- Sorsby’s fundus dystrophy --- Sorsby --- hereditary retinal dystrophy --- choroidal neovascularisation --- macular neovascularization --- anti-VEGF treatment --- long-term FU --- treatment outcome --- emerging treatment --- neovascular age-related macular degeneration (nAMD) --- Vascular Endothelial Growth Factor (VEGF) --- cataract surgery --- clinical trials --- real-world evidence --- AMD --- oct-angiography --- fellow eye --- choriocapillaris --- quiescent macular neovascularization --- ranibizumab --- aflibercept --- anti-VEGF --- visual acuity --- reading acuity --- disease activity --- treatment change --- treat and extend --- switch therapy --- retina --- choroidal neovascularization --- angiogenesis --- meteorin --- therapeutic innovation --- prevention --- nutrients --- lifestyle --- treatment-naive --- anti–vascular endothelial growth factor --- cardiovascular risk factors --- arterial hypertension --- macula-off rhegmatogenous detachment --- superficial perifoveal capillary plexus --- retinal deep perifoveal capillary plexus --- identification --- risk --- Delphi --- STARS® --- food supplement --- bevacizumab --- meta-analysis --- meta-regression --- n/a --- age-related macular degeneration (AMD) --- comparative therapies --- effectiveness --- intravitreal anti-vascular endothelial growth factor --- treat-and-extend --- pro re nata regimen --- Sorsby's fundus dystrophy
Choose an application
In this reprint, we hope to review the basics and highlight the latest developments in AMD. This demonstrates the benefits of the international scientific community working on this disease, to limit its negative impacts, the most vital of which is the loss of visual function, leading to a loss of autonomy and a decrease in patients’ quality of life.
Medicine --- aflibercept monotherapy --- polypoidal choroidal vasculopathy --- neovascular age-related macular degeneration --- good baseline visual acuity --- ForeseeHome AMD Monitoring System® --- AREDS2-HOME study --- age-related macular degeneration --- exudation --- optical coherence tomography angiography --- anti-vascular endothelial growth factor --- brolucizumab --- epithelial tear --- optical coherence tomography --- Sorsby's fundus dystrophy --- Sorsby --- hereditary retinal dystrophy --- choroidal neovascularisation --- macular neovascularization --- anti-VEGF treatment --- long-term FU --- treatment outcome --- emerging treatment --- neovascular age-related macular degeneration (nAMD) --- Vascular Endothelial Growth Factor (VEGF) --- cataract surgery --- clinical trials --- real-world evidence --- AMD --- oct-angiography --- fellow eye --- choriocapillaris --- quiescent macular neovascularization --- ranibizumab --- aflibercept --- anti-VEGF --- visual acuity --- reading acuity --- disease activity --- treatment change --- treat and extend --- switch therapy --- retina --- choroidal neovascularization --- angiogenesis --- meteorin --- therapeutic innovation --- prevention --- nutrients --- lifestyle --- treatment-naive --- cardiovascular risk factors --- arterial hypertension --- macula-off rhegmatogenous detachment --- superficial perifoveal capillary plexus --- retinal deep perifoveal capillary plexus --- identification --- risk --- Delphi --- STARS® --- food supplement --- bevacizumab --- meta-analysis --- meta-regression --- age-related macular degeneration (AMD) --- comparative therapies --- effectiveness --- intravitreal anti-vascular endothelial growth factor --- treat-and-extend --- pro re nata regimen
Listing 1 - 6 of 6 |
Sort by
|